BEAM

#1651
Beam Therapeutics Inc. Common Stock
31.00 USD
+2.31%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
30.32
31.00
Yıllık Aralık
15.35
36.44
Günlük Değişim
+2.31%
Aylık Değişim
+20.62%
6 aylık değişim
+13.35%
Yıllık Değişim
+82.68%
Önceki Kapanış
30.30
Open
30.32
Bid
Ask
Low
30.32
High
31.00
Hacim
43
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Beam Therapeutics Inc

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Haberler